Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Annals of Hepatology
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
Lucy Gracen, Withma Muthukumara, Melanie Aikebuse, Anthony Russell, James O'Beirne, Katharine M. Irvine, Suzanne Williams, Gaurav Puri, Patricia C. Valery, Kelly L. Hayward, Elizabeth E. Powell
10.1016/j.aohep.2023.101142
Ann Hepatol. 2023;28:
Full text access
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Raffaele Brustia, Mohamed Bouattour, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, Valérie Vilgrain, Edouard Larrey, Chetana Lim, Olivier Scatton, Sanaa El Mouhadi, Violaine Ozenne, François Paye, Pierre Balladur, Anthony Dohan, Pierre-Philippe Massault, Stanislas Pol, Marco Dioguardi Burgio, Ailton Sepulveda, Francois Cauchy, Alain Luciani, Daniele Sommacale, Vincent Leroy, Julien Calderaro, Francoise Roudot-Thoraval, Jean-Charles Nault, Giuliana Amaddeo
10.1016/j.aohep.2023.101141
Ann Hepatol. 2023;28:
Full text access
Comment on “Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c”
Zhenjing Wang, Nai Liu, Caixia Guo
10.1016/j.aohep.2023.101113
Ann Hepatol. 2023;28:
Full text access
Reply to: Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c
Hirsh D. Trivedi, Michelle Lai
10.1016/j.aohep.2023.101114
Ann Hepatol. 2023;28:
Full text access
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for
Marcos A. Thompson, Francisca Martinez-Barbini, Manuel Mendizabal
10.1016/j.aohep.2023.101081
Ann Hepatol. 2023;28:
Full text access
Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c
Hirsh D. Trivedi, Qua Tran, Zachary Fricker, Michael P. Curry, Jonathan X. Li, Michelle Lai
10.1016/j.aohep.2023.101087
Ann Hepatol. 2023;28:
Full text access
Patients with alcohol-related liver disease hospitalized during the COVID-19 pandemic experienced worse outcomes
Lindsay A Sobotka, Ayushi Jain, Jing Peng, Kenneth D Allen, Chelsey J McShane, Mitchell L Ramsey, Michael R Wellner, Robert B Kirkpatrick
10.1016/j.aohep.2023.101088
Ann Hepatol. 2023;28:
Full text access
P- 35 RELINKAGE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN THE CONTEXT OF THE COVID-19 PANDEMIC
Gisela Fabiana Sotera, Melina Ferreiro, Margarita Martes, Cordero Nancy, Jonathan Salmon, Juan Sordá, Jorge Daruich, Esteban González Ballerga
10.1016/j.aohep.2023.100937
Ann Hepatol. 2023;28 Supl 1:
Full text access
P- 76 ELEVATED FIBROSIS LEVEL IN PATIENTS COINFECTED WITH HEPATITIS AND COVID-19 DURING A LONGITUDINAL STUDY
Lucas Lima Da Silva, Vanessa Duarte Da Costa, Alanna Calheiros Santos, Juliana Custódio Miguel, Luciana Texeira De Barros E Vasconcellos, Wilian Jeans Wiggers, Claudia Alexandra Pontes Ivantes, Priscila Pollo-Flores, Lia Laura Lewis, Livia Melo Villar
10.1016/j.aohep.2023.100971
Ann Hepatol. 2023;28 Supl 1:
Full text access
P- 78 DIETHYlNITROSAMINE AND 2-ACETYLAMINOFLUORENE CHRONIC ADMINISTRATION LEADS TO BIOCHEMICAL, HISTOLOGIC AND GENETIC CHANGES RELATED TO HEPATOCELLULAR CARCINOMA IN WISTAR RATS
Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez-Rosales, Saraí Citlalic Rodríguez-Reyes, Erika Martínez-López, Juliana Marisol Godínez-Rubí, Adriana María Salazar-Montes, Laura Verónica Sánchez-Orozco
10.1016/j.aohep.2023.100973
Ann Hepatol. 2023;28 Supl 1:
Full text access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
